CLINICAL_TRIALS
research
· 2026-03-20
Clinical Trial Update: Natural History Study of Patients With Neurofibromatosis Type I
Summary
The National Cancer Institute is conducting an observational natural history study of patients with Neurofibromatosis Type 1. The study is currently active but …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibromatosis Type 1, Malignant Peripheral Nerve Sheath Tumor | Status: ACTIVE_NOT_RECRUITING